Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5M Buy
202,022
+106,293
+111% +$12.6M 1.01% 29
2025
Q4
$12.9M Buy
+95,729
New +$10.4M 0.52% 49

Other funds holding ABVX

Readystate Asset Management's ABVX Position: Q1 2026 in Review

Readystate Asset Management increased its Abivax (ABVX) stake by 111% in Q1 2026, buying an estimated $12.6M and bringing the position to 202,022 shares worth $22.5M. The position accounts for 1.01% of the portfolio, ranked #29.

Readystate Asset Management first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Readystate Asset Management held 202,022 shares of Abivax worth $22.5M as of Q1 2026.
  • Readystate Asset Management bought 106,293 Abivax shares in Q1 2026, an estimated $12.6M.
  • Abivax made up 1.01% of Readystate Asset Management's portfolio in Q1 2026, its #29 holding.
  • Readystate Asset Management first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.